for us brands

The German market is opening. You Don't Need to Be There to Win.

Germany legalized cannabis cultivation through Cannabis Social Clubs in 2024. Up to 3,000 clubs are projected. Every single one needs what you already have: proven cultivation methods, quality standards, and operational know-how.
The problem: Direct market entry is a regulatory minefield. The solution: Strategic knowledge transfer and brand licensing through local partners — managed by resolyze.
50+
CSC network access
2–3 yr.
Full market penetration horizon
250K€
Typical entry project cost
0
Operational risk on your side
THE GERMAN MARKET
What you need to know.
83 million people. 4.5 million cannabis consumers. A legal framework that's built for clubs, not corporations. Germany didn't legalize commercial cannabis sales. It legalized non-commercial Cannabis Social Clubs (CSCs) — member-owned cultivation cooperatives with up to 500 members each, operating under the KCanG (Cannabis Consumption Act).
What that means for you:
No retail licenses. No dispensaries. No import of THC products. The only legal path to the German market is through CSCs — and CSCs need exactly what US legacy brands have built over the past decade: SOPs, cultivation expertise, quality systems, and brand knowledge.
The numbers:
368 of 806 CSC applications approved as of December 2025. Government projection: up to 3,000 clubs. Current capacity covers less than 2% of demand. The gap between supply and demand is enormous — and it's not a production gap. It's a knowledge gap.
The regulatory reality:
The KCanG prohibits advertising (§6), mandates comprehensive documentation, and authorizes fines up to €30,000 for compliance violations. Clubs that fail on communication, documentation, or quality control lose their license. Most clubs have no experience in regulated cannabis markets. US legacy brands do.
WHY DIRECT ENTRY DOESN'T WORK
Every US brand that tries to enter Germany directly faces the same four problems.
Regulatory complexity.
German cannabis law has nothing in common with US state regulations. The CSC model is non-commercial, member-only, and governed by association law — not business law. Your US legal team won't know where to start.
No import path.
THC products cannot be imported into Germany. Medical cannabis has strict import regulations. Your flower, concentrates, and edibles cannot cross the border. Physical product export is not an option.
Cultural mismatch.
German cannabis consumers are quality-conscious but price-sensitive. The CSC model is community-driven, not brand-driven. American marketing playbooks don't translate — and aggressive branding violates the advertising ban.
Capital at risk.
Direct market entry requires €500K+ in legal fees, entity setup, facility investment, and regulatory compliance — with no guarantee of approval. Several US-backed ventures have already pulled out after burning through six figures.
The alternative: Transfer your knowledge, not your capital.
THE RESOLYZE MODEL
Your expertise enters the German market. Your risk doesn't.
Instead of direct entry, resolyze offers a three-stage model that puts your knowledge, SOPs, and brand into the German market through strategic CSC partnerships — without requiring you to set up a German entity, hire local staff, or navigate the regulatory maze yourself.
Stage 1: Market Analysis & Entry Strategy
Timeline: 4–6 weeks.
We assess your brand, your product portfolio, and your goals for the German market. You receive a realistic picture — not a sales pitch. What translates to Germany, what doesn't, and what the optimal entry model looks like for your specific situation.
Deliverables: Market opportunity assessment, regulatory mapping (US vs. DE for your products), entry model recommendation, ROI scenario planning.
Stage 2: Partner Matching & Contract Design
Timeline: 6–8 weeks.
We identify CSCs in our network that match your brand philosophy, quality standards, and geographic priorities. We design the partnership structure: licensing terms, knowledge transfer scope, quality assurance protocols, and IP protection mechanisms.
Deliverables: Partner shortlist with qualification profiles, draft licensing agreement, knowledge transfer framework, IP protection structure.
Stage 3: Guided Implementation
Timeline: 3–6 months.
We manage the handover: training CSC cultivation teams on your SOPs, adapting your methods to KCanG requirements, establishing quality monitoring, and supporting the first production cycles. You stay involved through defined checkpoints — without being operationally responsible.
Deliverables: Adapted SOP package for German CSCs, training program, quality monitoring framework, ongoing reporting.
PROTECTING YOUR INTELLECTUAL PROPERTY
The question every US brand asks first — answered with substance.
We understand that your SOPs, genetics knowledge, and brand are your most valuable assets. Sharing them with foreign partners without bulletproof protection is a non-starter. Here's how we handle it:
Staged disclosure model. No sensitive information is shared before a binding agreement is signed. Stage 1 (Market Analysis) requires zero IP from you. Stage 2 involves high-level brand and product discussions under NDA. Stage 3 transfers specific SOPs only after the licensing agreement is executed.
Contractual protection. All partnership agreements include non-compete clauses, usage restrictions, quality mandates, and termination rights. Contracts are governed by German law with international arbitration options. We work with German IP attorneys who specialize in cross-border licensing.
Practical protection. SOPs are transferred in modular form — partners receive what they need to execute, not your entire playbook. Core proprietary methods can be retained and delivered through ongoing consulting rather than documentation. Training is conducted by resolyze, not by sharing raw documents.
What we cannot guarantee: German association law is new and evolving. The KCanG has been in effect since April 2024. Case law is limited. We design contracts based on current best practices and update them as the regulatory landscape develops. We're transparent about what's tested and what's new — because that's the only way to build trust.
WHO WE ARE
Why we bridge both markets
Christoph Schubert
Technical Partner — Indoor Farming & Anlagentechnik
20+ years in high-tech indoor farming and plant lighting. Direct partnerships with US legacy brands in California and Canada. Christoph doesn't just understand German growing conditions — he's spent years working with the methods that made US craft cannabis what it is. He translates between both worlds: American cultivation innovation and German regulatory precision.
Stephan Krüger
Strategic Partner — Indoor Farming & Anlagentechnik
20+ years in strategy, brand, and compliance communication for regulated B2B markets. Author of the industry's first compliance workbook for German CSCs ("Rechtssichere Öffentlichkeitsarbeit"). Stephan understands what German regulators expect — and builds the communication frameworks that keep CSC partners compliant.
Together: resolyze is the only consultancy in the German market that integrates regulatory compliance, operational process standards (SOPs), and technical cultivation expertise. For US brands, that means one partner instead of three — and a team that speaks both American cannabis and German regulation.
FREQUENTLY ASKED QUESTIONS

Good to know.

Can we export our products directly to Germany?
No. Direct import of THC-containing cannabis products is prohibited. Even medical cannabis faces strict import regulations. Our model focuses on knowledge and brand transfer, not physical product export.
How does the German CSC model differ from US dispensaries?
Fundamentally. CSCs are non-commercial, member-only cultivation cooperatives. No retail, no storefronts, no advertising. Members grow collectively and distribute at cost. The model is closer to a craft beer homebrew co-op than to a dispensary chain.
What types of IP can we transfer?
Primarily: cultivation SOPs, process knowledge, quality standards, and brand licensing. Genetic material cannot be directly imported, but your methods for achieving specific quality profiles can be transferred and applied to legally available genetics in Germany.
What's the realistic timeline for seeing revenue?
From first engagement to functioning CSC partnerships: 6–12 months. Licensing revenue begins when partner CSCs are operational. Full market penetration is a 2–3 year horizon. The advantage over direct entry: significantly lower risk and earlier breakeven.
What happens if German cannabis law changes?
The coalition agreement (2025) includes an "open-ended evaluation" of the KCanG in autumn 2025. Full repeal is considered unlikely (SPD resistance, Bundesrat hurdle, practical implementation problems). Tightening in specific areas is possible. Our contracts include regulatory change clauses, and our model is designed to adapt.
How many CSCs can we partner with?
There's no legal limit on the number of licensing partnerships. Our network includes clubs across Germany, with varying sizes, philosophies, and geographic footprints. We match based on brand fit, not volume.